Andrew S. Goldstein, Ph.D.

Affiliations: 
2011 University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology, Cell Biology, Oncology
Google:
"Andrew Goldstein"

Parents

Sign in to add mentor
Owen N. Witte grad student 2011 UCLA
 (A role for stem/progenitor cells in the initiation of epithelial cancers.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Giafaglione JM, Crowell PD, Delcourt AML, et al. (2023) Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment. Nature Cell Biology
Wang CW, Clémot M, Hashimoto T, et al. (2023) A conserved mechanism for JNK-mediated loss of Notch function in advanced prostate cancer. Science Signaling. 16: eabo5213
Crowell PD, Giafaglione JM, Jones AE, et al. (2023) MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer. Cell Reports. 42: 113221
Bernard MJ, Smith CM, Goldstein AS. (2023) Prostatic proliferative inflammatory atrophy: welcome to the club. The Journal of Pathology
Fox JJ, Hashimoto T, Navarro HI, et al. (2023) Highly multiplexed immune profiling throughout adulthood reveals kinetics of lymphocyte infiltration in the aging mouse prostate. Aging. 15
Payne MC, Ho S, Hashimoto T, et al. (2023) Microwell-based flow culture increases viability and restores drug response in prostate cancer spheroids. Biotechnology Journal. e2200434
Freeland J, Crowell PD, Giafaglione JM, et al. (2021) Aging of the progenitor cells that initiate prostate cancer. Cancer Letters. 515: 28-35
Crowell PD, Giafaglione JM, Hashimoto T, et al. (2020) Distinct cell-types in the prostate share an aging signature suggestive of metabolic reprogramming. American Journal of Clinical and Experimental Urology. 8: 140-151
Crowell PD, Giafaglione JM, Hashimoto T, et al. (2019) Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture. Journal of Visualized Experiments : Jove
Li Y, He Y, Butler W, et al. (2019) Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer. Science Translational Medicine. 11
See more...